In patients with pulmonary fibrosis, increased levels of CXCL9, CXCL10, CCL18, CTO, and CA15.3 are accompanied by elevated SP-D, a component of lung surfactant and a pattern-recognition molecule produced by alveolar type II cells and Clara cells. Here, CCL18 is linked to pulmonary fibrosis.